Search

for
Search:

Sort by

Research

60-90 / 1000+ results

Comparative Trial on Efficacy of Topical Contact Immunotherapy with Dinitrochlorobenzene and Diphenylcyclopropenone in Alopecia Areata

research Comparative trail on efficacy of topical contact immunotherapy with dinitrochlorobenzene and diphenylcyclopropenone in alopecia areata

July 2021 in “International journal of dermatology, venereology and leprosy sciences”

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

research 11β-Hydroxylase inhibitors protect against seizures in mice by increasing endogenous neurosteroid synthesis

18 citations , April 2011 in “Neuropharmacology”

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

research The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma

21 citations , November 2018 in “Journal of the European Academy of Dermatology and Venereology”

The combination of encorafenib and binimetinib caused few skin issues.

4-(Alkylthio)- and 4-(Arylthio)-Benzonitrile Derivatives as Androgen Receptor Antagonists for the Topical Suppression of Sebum Production

research 4-(Alkylthio)- and 4-(arylthio)-benzonitrile derivatives as androgen receptor antagonists for the topical suppression of sebum production

11 citations , March 2009 in “Bioorganic & Medicinal Chemistry Letters”

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

research Cosmeceutical Potentials of Equisetum debile Roxb. ex Vaucher Extracts

January 2023 in “Applied sciences”

Equisetum debile extracts may help with skin whitening, anti-wrinkle, and anti-hair loss treatments.

research Adverse Systemic Reaction to Dinitrochlorobenzene

14 citations , June 1982 in “Archives of Dermatology”

A man had bad reactions to a hair loss treatment called DNCB.

research Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment

25 citations , October 2010 in “Journal of Hepatology”

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

research Finasteride < Rec INN; BAN; USAN >

5 citations , January 1991 in “Drugs of The Future”

research Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog

January 2025 in “Ciência Rural”

Improper use of benzyl benzoate on a dog can cause severe skin reactions.

research Combination oral minoxidil and baricitinib treatment of alopecia areata

5 citations , May 2025 in “Journal of the American Academy of Dermatology”

research Serum Biotinidase Activity in Children Treated With Valproic Acid and Carbamazepine

16 citations , May 2009 in “Journal of child neurology”

Valproic acid does not change biotinidase enzyme activity in children's blood.

research Preparation, solubility, and anti-inflammatory effects of a complex of diphenylcyclopropenone/β-cyclodextrin derivatives as the treatment of alopecia areata

1 citations , August 2024 in “Journal of Pharmacy & Pharmaceutical Sciences”

The DPCP/HPβCD complex improves solubility and anti-inflammatory effects for alopecia areata treatment.

research Synthesis and Evaluation of 2‘-Substituted 4-(4‘-Carboxy- or 4‘-carboxymethylbenzylidene)-N-acylpiperidines: Highly Potent and in Vivo Active Steroid 5α-Reductase Type 2 Inhibitors

22 citations , June 2002 in “Journal of Medicinal Chemistry”

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials

research Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials

November 2025 in “SKIN The Journal of Cutaneous Medicine”

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

research Minoxidil

June 2015 in “Reactions weekly”

research Minoxidil

December 2012 in “Reactions weekly”

research Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes

August 2022 in “Journal of Investigative Dermatology”

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

research The Influence of Valproic Acid and Carbamazepine Treatment on Serum Biotin and Zinc Levels and on Biotinidase Activity

21 citations , June 2011 in “Journal of child neurology”

Valproic acid and carbamazepine do not change biotin or biotinidase levels but may lower zinc levels, still within normal range.

Synthesis and Biological Evaluation of 4-(4-(Alkyl- and Phenylaminocarbonyl)benzoyl)benzoic Acid Derivatives as Non-Steroidal Inhibitors of Steroid 5α-Reductase Isozymes 1 and 2

research Synthesis and Biological Evaluation of 4-(4-(Alkyl-and Phenylaminocarbonyl)benzoyl)benzoic Acid Derivatives as Non-steroidal Inhibitors of Steroid 5α-Reductase Isozymes 1 and 2

8 citations , March 2002 in “Archiv Der Pharmazie”

The compound 4c effectively inhibits the enzyme linked to hair loss.

research The selective androgen receptor modulator GTx‐024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double‐blind, placebo‐controlled phase II trial

306 citations , August 2011 in “Journal of cachexia, sarcopenia and muscle”

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

research Rational Design and Synthesis of 4-((1R,2R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a Novel, Nonsteroidal Androgen Receptor Antagonist Devoid of Phototoxicity for Dermatological Indications

23 citations , October 2008 in “Journal of medicinal chemistry”

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

research Prooxidant and antioxidant action of 4-(4-phenoxybenzoyl)benzoic acid derivatives

2 citations , February 2004 in “Biopolymers”

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.